FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’ Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer's disease Melissa Rudy By Melissa Rudy Fox News Published July 2, 2024 5:04pm EDT

FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’ Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer's disease Melissa Rudy By Melissa Rudy Fox News Published July 2, 2024 5:04pm EDT https://www.foxnews.com/health/fda-approves-new-drug-alzheimers-disease-meaningful-results